NCT07518329
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07518329
Title Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. (SAPPHIRE)
Acronym SAPPHIRE
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arovella Therapeutics Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
St. Vincent's Hospital NOT_YET_RECRUITING Sydney New South Wales 2010 Australia Details
Mater Misericordiae Ltd (MML) NOT_YET_RECRUITING Brisbane Queensland 4101 Australia Details
Royal Adelaide Hospital NOT_YET_RECRUITING Adelaide South Australia 5000 Australia Details
The Alfred Hospital RECRUITING Melbourne Victoria 3004 Australia Details
Epworth HealthCare NOT_YET_RECRUITING Richmond Victoria 3121 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field